http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2538703-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fa6178d16675e11ae09ee4bd579cb0b0 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4174 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61J3-04 |
| filingDate | 2013-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aef6e154460dc409bcc54e3fab81e1b3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ea689387dc70207c00efad496feba06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3c089cd31808f8e44b6f1e51b817ea7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3612f972c464b3357a5bcf6720b7a9b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5306e15a34bf099ade5a4bcb12fee8b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c07c412898ab4f67e3acaa1857664c2 |
| publicationDate | 2015-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2538703-C2 |
| titleOfInvention | Pharmaceutical composition for treating vaginal candidiasis and method for preparing it |
| abstract | FIELD: medicine. n SUBSTANCE: as an active substance, the composition contains butoconazol, a base that is a combination of a hydrophobic ingredient, a hydrophilic ingredient and an emulsifier, and also a gel-forming polymer. Hydroxypropylstarch phosphate is preferentially used as the gel-forming polymer. A method for preparing the declared composition consists in the fact that a mixture of butoconazol with a portion of the hydrophilic ingredient, the hydrophobic ingredient and emulsifier is added with a dispersion of the gel-forming polymer in the rest of the hydrophilic ingredient; the produced mixture is agitated homogenously with a preserving agent added where it might be necessary. n EFFECT: new pharmaceutical composition is characterised by a high level of antifungal activity, stability both at a storage temperature, and at a use temperature, and good pack extrusion. n 14 cl, 2 tbl, 10 ex |
| priorityDate | 2013-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 109.